Spun off from Danaher (DHR) and operating according to a broadly similar business philosophy, Fortive (FTV)
 has long enjoyed a benefit of the doubt with the Street, and that seems
 to be even more the case today. I like Fortive, but I’m surprised at 
how willing the Street is in this case to overlook fairly meaningful 
short-cycle exposure, broadening (or loosening) M&A standards, and a
 rich valuation for a company that doesn’t (yet) have the sort of 
recurring revenue mix or margin structure of companies like Danher or Roper (ROP).
I
 have little doubt that I’ll hear from Fortive shareholders for those 
comments, but so be it. Like I said, I like this company, and I like the
 direction it's heading – the premiums management is paying for M&A 
concern me, but I agree with the strategic rationales for the deals 
they’re doing. With the implied return looking pretty similar to Danaher
 and Roper, I’d rather overpay for those two than Fortive at this point 
in time.
Click here for more:
Fortive's Valuation Already Assumes A Lot Of Improvement
No comments:
Post a Comment